A novel combination of drug therapy to protect residual hearing post cochlear implant surgery.
about
Intracochlear drug delivery in combination with cochlear implants : Current aspects[Intracochlear drug delivery in combination with cochlear implants : Current aspects].Perilymph pharmacokinetics of marker applied through a cochlear implant in guinea pigs.Emerging Therapies for Sensorineural Hearing Loss.
P2860
A novel combination of drug therapy to protect residual hearing post cochlear implant surgery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A novel combination of drug th ...... post cochlear implant surgery.
@en
A novel combination of drug th ...... post cochlear implant surgery.
@nl
type
label
A novel combination of drug th ...... post cochlear implant surgery.
@en
A novel combination of drug th ...... post cochlear implant surgery.
@nl
prefLabel
A novel combination of drug th ...... post cochlear implant surgery.
@en
A novel combination of drug th ...... post cochlear implant surgery.
@nl
P2093
P2860
P1476
A novel combination of drug th ...... post cochlear implant surgery.
@en
P2093
Adrien A Eshraghi
Blake Bauer
Esperanza Bas
Fred F Telischi
Ileana Rivera
Jeenu Mittal
Jonathan Roell
Mateo Guardiola
Noah Shaikh
Thomas Van De Water
P2860
P304
P356
10.3109/00016489.2015.1134809
P407
P577
2016-02-06T00:00:00Z